Reduction in transplant-related complications in patients given intravenous immune globulin after allogeneic marrow transplantation

Clinical and Experimental Immunology, Supplement

Volumn 97, Issue 1, 1994, Pages 53-57

  Siadak, M F ^a   Kopecky, K ^a   Sullivan, K M ^a  

^a FRED HUTCHINSON CANCER RESEARCH CENTER   (United States)

Author keywords

bone marrow transplantation; CMV; GVHD; IVIG

Indexed keywords

IMMUNOGLOBULIN;

ALLOGENIC BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOPROPHYLAXIS; IMMUNOTHERAPY; INFECTION RESISTANCE; INTERSTITIAL PNEUMONIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SEPTICEMIA;

BONE MARROW TRANSPLANTATION; CLINICAL TRIALS; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0027936579     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)